Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 11, 2022

SELL
$11.79 - $27.63 $14.4 Million - $33.8 Million
-1,222,571 Closed
0 $0
Q1 2022

Apr 20, 2022

BUY
$20.67 - $40.33 $2.26 Million - $4.4 Million
109,115 Added 9.8%
1,222,571 $31.9 Million
Q4 2021

Jan 14, 2022

BUY
$36.68 - $54.02 $1.5 Million - $2.21 Million
40,825 Added 3.81%
1,113,456 $44.1 Million
Q3 2021

Oct 26, 2021

SELL
$49.57 - $58.15 $189,654 - $222,481
-3,826 Reduced 0.36%
1,072,631 $53.6 Million
Q2 2021

Jul 26, 2021

BUY
$47.17 - $58.64 $2.44 Million - $3.03 Million
51,747 Added 5.05%
1,076,457 $59.8 Million
Q1 2021

Apr 21, 2021

SELL
$42.51 - $54.07 $3.4 Million - $4.32 Million
-79,957 Reduced 7.24%
1,024,710 $47.9 Million
Q4 2020

Jan 22, 2021

BUY
$31.9 - $44.89 $3.79 Million - $5.34 Million
118,965 Added 12.07%
1,104,667 $48.1 Million
Q3 2020

Oct 08, 2020

BUY
$28.55 - $36.91 $28.1 Million - $36.4 Million
985,702 New
985,702 $36.1 Million

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $378M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Riverbridge Partners LLC Portfolio

Follow Riverbridge Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverbridge Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverbridge Partners LLC with notifications on news.